ARKB vs ARKG

ARK 21Shares Bitcoin ETF vs ARK Genomic Revolution ETF

Quick take
  • ARKB has the lower expense ratio at 0.21% vs 0.75% for ARKG.

Side-by-side metrics

MetricARKBARKG
Expense ratio
Annual fee. Lower is better.
0.21%0.75%
Dividend yield
Trailing 12-month yield.
0.00%0.00%
AUM
Assets under management — bigger funds are typically more liquid.
$2.84B$1.24B
YTD return
-6.92%7.21%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.002.35
P/E ratio
Last price
$26.58$30.38
Inception
Issuer
ARKARK

ARKB top holdings

Holdings data unavailable for ARKB.

ARKG top holdings

Top holdings · ARKG
TEMTempus AI Inc Class A common stock9.45%
TWSTTwist Bioscience Corp9.02%
CRSPCRISPR Therapeutics AG8.94%
TXG10x Genomics Inc Ordinary Shares - Class A5.78%
BEAMBeam Therapeutics Inc5.44%
ABSIAbsci Corp4.79%
NTRANatera Inc4.08%
ILMNIllumina Inc4.04%
NTLAIntellia Therapeutics Inc3.83%
PSNLPersonalis Inc3.59%
Sector breakdown · ARKG
Healthcare100.0%

About ARKB

ARKB (ARK 21Shares Bitcoin ETF) is Spot Bitcoin ETF from ARK and 21Shares. Managed by ARK, the fund carries $2.8B in assets under management, an expense ratio of 0.21%.

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Tempus AI Inc Class A common stock (TEM), which represents 9.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.